Presentation is loading. Please wait.

Presentation is loading. Please wait.

Sirolimus Ameliorated Post Lung Transplant Chylothorax in Lymphangioleiomyomatosis  Toshiaki Ohara, MD, Takahiro Oto, MD, Kentaro Miyoshi, MD, Hiroyuki.

Similar presentations


Presentation on theme: "Sirolimus Ameliorated Post Lung Transplant Chylothorax in Lymphangioleiomyomatosis  Toshiaki Ohara, MD, Takahiro Oto, MD, Kentaro Miyoshi, MD, Hiroyuki."— Presentation transcript:

1 Sirolimus Ameliorated Post Lung Transplant Chylothorax in Lymphangioleiomyomatosis 
Toshiaki Ohara, MD, Takahiro Oto, MD, Kentaro Miyoshi, MD, Hiroyuki Tao, MD, Masaomi Yamane, MD, Shinichi Toyooka, MD, Megumi Okazaki, RN, Hiroshi Date, MD, Yoshifumi Sano, MD  The Annals of Thoracic Surgery  Volume 86, Issue 6, Pages e7-e8 (December 2008) DOI: /j.athoracsur Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Abdominal computed tomographic scan shows reduced chylous peritoneal effusions after initiation of the sirolimus therapy. (A) Before and (B) after sirolimus therapy. The Annals of Thoracic Surgery  , e7-e8DOI: ( /j.athoracsur ) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Amount of total drainage of chylous pleural effusion was reduced after initiation of sirolimus therapy. (Arrows = pleurodesis with minomycin only, OK-432 only, and combined use of minomycin and OK-432; SSTN = somatostatine analog administration.) The Annals of Thoracic Surgery  , e7-e8DOI: ( /j.athoracsur ) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions


Download ppt "Sirolimus Ameliorated Post Lung Transplant Chylothorax in Lymphangioleiomyomatosis  Toshiaki Ohara, MD, Takahiro Oto, MD, Kentaro Miyoshi, MD, Hiroyuki."

Similar presentations


Ads by Google